| UniProt ID | DBLOH_HUMAN | |
|---|---|---|
| UniProt AC | Q9NR28 | |
| Protein Name | Diablo homolog, mitochondrial | |
| Gene Name | DIABLO | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 239 | |
| Subcellular Localization | Mitochondrion . Released into the cytosol when cells undergo apoptosis. | |
| Protein Description | Promotes apoptosis by activating caspases in the cytochrome c/Apaf-1/caspase-9 pathway. Acts by opposing the inhibitory activity of inhibitor of apoptosis proteins (IAP). Inhibits the activity of BIRC6/bruce by inhibiting its binding to caspases. Isoform 3 attenuates the stability and apoptosis-inhibiting activity of XIAP/BIRC4 by promoting XIAP/BIRC4 ubiquitination and degradation through the ubiquitin-proteasome pathway. Isoform 3 also disrupts XIAP/BIRC4 interacting with processed caspase-9 and promotes caspase-3 activation. Isoform 1 is defective in the capacity to down-regulate the XIAP/BIRC4 abundance.. | |
| Protein Sequence | MAALKSWLSRSVTSFFRYRQCLCVPVVANFKKRCFSELIRPWHKTVTIGFGVTLCAVPIAQKSEPHSLSSEALMRRAVSLVTDSTSTFLSQTTYALIEAITEYTKAVYTLTSLYRQYTSLLGKMNSEEEDEVWQVIIGARAEMTSKHQEYLKLETTWMTAVGLSEMAAEAAYQTGADQASITARNHIQLVKLQVEEVHQLSRKAETKLAEAQIEELRQKTQEEGEERAESEQEAYLRED | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | Phosphorylation | --MAALKSWLSRSVT --CHHHHHHHHHHHH | 33.81 | 21712546 | |
| 9 | Phosphorylation | AALKSWLSRSVTSFF HHHHHHHHHHHHHHH | 19.09 | 21712546 | |
| 11 | Phosphorylation | LKSWLSRSVTSFFRY HHHHHHHHHHHHHHH | 26.77 | 27251275 | |
| 13 | Phosphorylation | SWLSRSVTSFFRYRQ HHHHHHHHHHHHHHH | 22.51 | 21712546 | |
| 14 | Phosphorylation | WLSRSVTSFFRYRQC HHHHHHHHHHHHHHH | 21.89 | 24719451 | |
| 62 | Ubiquitination | CAVPIAQKSEPHSLS EECCCCCCCCCCCCC | 48.00 | - | |
| 67 | Phosphorylation | AQKSEPHSLSSEALM CCCCCCCCCCHHHHH | 40.43 | 27251275 | |
| 69 | Phosphorylation | KSEPHSLSSEALMRR CCCCCCCCHHHHHHH | 29.19 | 28857561 | |
| 70 (in isoform 2) | Ubiquitination | - | 31.98 | 21890473 | |
| 70 | Phosphorylation | SEPHSLSSEALMRRA CCCCCCCHHHHHHHH | 31.98 | 27251275 | |
| 93 (in isoform 2) | Ubiquitination | - | 10.12 | 21890473 | |
| 108 | Phosphorylation | TEYTKAVYTLTSLYR HHHHHHHHHHHHHHH | 10.82 | 28442448 | |
| 109 | Phosphorylation | EYTKAVYTLTSLYRQ HHHHHHHHHHHHHHH | 19.57 | 28442448 | |
| 111 | Phosphorylation | TKAVYTLTSLYRQYT HHHHHHHHHHHHHHH | 14.64 | 28442448 | |
| 112 | Phosphorylation | KAVYTLTSLYRQYTS HHHHHHHHHHHHHHH | 26.90 | 28442448 | |
| 114 | Phosphorylation | VYTLTSLYRQYTSLL HHHHHHHHHHHHHHH | 8.74 | 28442448 | |
| 123 | Ubiquitination | QYTSLLGKMNSEEED HHHHHHHCCCCCCHH | 34.57 | 20639865 | |
| 124 | Sulfoxidation | YTSLLGKMNSEEEDE HHHHHHCCCCCCHHH | 6.73 | 30846556 | |
| 126 | Phosphorylation | SLLGKMNSEEEDEVW HHHHCCCCCCHHHHH | 42.77 | 27251275 | |
| 138 (in isoform 2) | Ubiquitination | - | 9.63 | 21890473 | |
| 146 | Acetylation | ARAEMTSKHQEYLKL HHHHCCHHHHHHHHH | 39.89 | 25825284 | |
| 146 | Ubiquitination | ARAEMTSKHQEYLKL HHHHCCHHHHHHHHH | 39.89 | 21906983 | |
| 147 | Ubiquitination | RAEMTSKHQEYLKLE HHHCCHHHHHHHHHH | 26.02 | 21890473 | |
| 150 (in isoform 2) | Ubiquitination | - | 11.54 | 21890473 | |
| 154 (in isoform 2) | Ubiquitination | - | 42.47 | 21890473 | |
| 159 | Ubiquitination | KLETTWMTAVGLSEM HHHHHHHHHHHHHHH | 15.11 | 21890473 | |
| 163 | Ubiquitination | TWMTAVGLSEMAAEA HHHHHHHHHHHHHHH | 2.93 | 21890473 | |
| 164 | Phosphorylation | WMTAVGLSEMAAEAA HHHHHHHHHHHHHHH | 21.28 | 30175587 | |
| 166 (in isoform 2) | Ubiquitination | - | 3.73 | 21890473 | |
| 191 | Ubiquitination | RNHIQLVKLQVEEVH HHHHEEEEEHHHHHH | 41.62 | 21890473 | |
| 199 (in isoform 1) | Ubiquitination | - | 46.43 | 21890473 | |
| 203 | Ubiquitination | EVHQLSRKAETKLAE HHHHHHHHHHHHHHH | 47.39 | 21890473 | |
| 207 | Acetylation | LSRKAETKLAEAQIE HHHHHHHHHHHHHHH | 36.89 | 25953088 | |
| 207 | Ubiquitination | LSRKAETKLAEAQIE HHHHHHHHHHHHHHH | 36.89 | 21890473 | |
| 219 | Ubiquitination | QIEELRQKTQEEGEE HHHHHHHHHHHHHHH | 45.82 | 21906983 | |
| 220 | Phosphorylation | IEELRQKTQEEGEER HHHHHHHHHHHHHHH | 32.64 | 22817900 | |
| 222 (in isoform 1) | Ubiquitination | - | 73.52 | 21890473 | |
| 230 | Phosphorylation | EGEERAESEQEAYLR HHHHHHHHHHHHHHC | 43.53 | 25849741 | |
| 235 | Phosphorylation | AESEQEAYLRED--- HHHHHHHHHCCC--- | 12.92 | 23186163 | |
| 267 (in isoform 1) | Ubiquitination | - | 21890473 | ||
| 279 (in isoform 1) | Ubiquitination | - | 21890473 | ||
| 283 (in isoform 1) | Ubiquitination | - | 21890473 | ||
| 295 (in isoform 1) | Ubiquitination | - | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 6 | S | Phosphorylation | Kinase | MAPK8 | P45983 | GPS |
| 9 | S | Phosphorylation | Kinase | MAPK8 | P45983 | GPS |
| 67 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | BIRC3 | Q13489 | PMID:12525502 |
| - | K | Ubiquitination | E3 ubiquitin ligase | BIRC6 | Q9NR09 | PMID:15300255 |
| - | K | Ubiquitination | E3 ubiquitin ligase | BIRC7 | Q96CA5 | PMID:16729033 |
| - | K | Ubiquitination | E3 ubiquitin ligase | XIAP | P98170 | PMID:12121969 |
| - | K | Ubiquitination | E3 ubiquitin ligase | BIRC2 | Q13490 | PMID:14960576 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DBLOH_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DBLOH_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 614152 | Deafness, autosomal dominant, 64 (DFNA64) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...